Target treatments for cancer by way of surgery combined with chemical hyperthermia, using physical agents (conformal radiotherapy, isotopes and brachytherapy), and chemotherapy (pharmacokinetics and population models).
- Team 1 run by Olivier Glehen: animal models and peritoneal carcinosis, evaluation of targeted intraperitoneal therapy on animal models, and phase II clinical trials (National centre of excellence)
- Team 2 run by Gilles Freyer: evaluation of the pharmacokinetics of anti-cancer drugs and the impact of pharmacokinetics on anti-tumoral efficacy, construction of population models, phase I and phase II clinical trials.
- Team 3 run by Olivier Chapet: evaluation of conformal radiotherapy, the use of 3D imaging in increasing the precision of ballistic targeting, phase III clinical trials.
- Team 4 run by Claire Rodriguez Lafrasse: radiobiology and the study of molecular resistance of cancer cells to irradiation (X rays, electrons, carbon ions)
